Search Results - "Ballreich, Jeromie M"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs by Murimi-Worstell, Irene B, Ballreich, Jeromie M, Seamans, Marissa J, Alexander, G Caleb

    Published in PloS one (12-11-2019)
    “…Despite the importance of pharmacopeial standards, little is known regarding their effect on drug competition. Such information is of particular relevance…”
    Get full text
    Journal Article
  2. 2

    Examining Opportunities to Increase Savings From Medicare Price Negotiations by Reitsma, Marissa B, Dusetzina, Stacie B, Ballreich, Jeromie M, Trujillo, Antonio J, Mello, Michelle M

    Published in JAMA internal medicine (01-06-2023)
    “…Allowing the US Centers for Medicare & Medicaid Services to negotiate prescription drug prices for Medicare may improve drug affordability. To estimate savings…”
    Get more information
    Journal Article
  3. 3

    Strategic Manufacturer Response to the Medicaid Rebate Cap Removal by Levy, Joseph F., Socal, Mariana P., Ballreich, Jeromie M.

    Published in JAMA health forum (01-11-2024)
    “…This economic evaluation illustrates a manufacturer’s estimated spending and revenues as it discontinued a branded product and introduced a generic replacement…”
    Get full text
    Journal Article
  4. 4

    Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers by Heyward, James, Jones, Christopher M, Compton, Wilson M, Lin, Dora H, Losby, Jan L, Murimi, Irene B, Baldwin, Grant T, Ballreich, Jeromie M, Thomas, David A, Bicket, Mark C, Porter, Linda, Tierce, Jonothan C, Alexander, G Caleb

    Published in JAMA network open (05-10-2018)
    “…Despite epidemic rates of addiction and death from prescription opioids in the United States, suggesting the importance of providing alternatives to opioids in…”
    Get full text
    Journal Article
  5. 5

    Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019 by Ballreich, Jeromie M, Gross, Cary P, Powe, Neil R, Anderson, Gerard F

    Published in JAMA network open (04-01-2021)
    “…Prior research suggests an association between burden of disease and National Institutes of Health (NIH) funding. The allocation of NIH funding should reflect,…”
    Get full text
    Journal Article
  6. 6

    Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019 by Plummer, Elizabeth, Socal, Mariana P, Ballreich, Jeromie M, Anderson, Gerard F, Bai, Ge

    Published in JAMA health forum (06-05-2022)
    “…This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019 by Hussaini, S M Qasim, Gupta, Arjun, Anderson, Kelly E, Ballreich, Jeromie M, Nicholas, Lauren Hersch, Alexander, G Caleb

    Published in JAMA network open (01-03-2022)
    “…This cross-sectional study examines utilization trends for filgrastim and infliximab products and their biosimilars to understand whether biosimilars are…”
    Get full text
    Journal Article
  9. 9

    Biosimilar uptake of filgrastim and impact on spending in Medicare Part D from 2015 to 2019 by Hussaini, Syed, Gupta, Arjun, Anderson, Kelly E., Ballreich, Jeromie M., Nicholas, Lauren H., Alexander, Caleb

    Published in Journal of clinical oncology (01-10-2021)
    “…Abstract only 67 Background: The introduction of a filgrastim biosimilar in 2014 was associated with substantial cost savings in Medicare Part B and Medicaid…”
    Get full text
    Journal Article
  10. 10

    Association between US Pharmacopeia by Murimi-Worstell, Irene B, Ballreich, Jeromie M, Seamans, Marissa J, Alexander, G. Caleb

    Published in PloS one (12-11-2019)
    “…Despite the importance of pharmacopeial standards, little is known regarding their effect on drug competition. Such information is of particular relevance…”
    Get full text
    Journal Article
  11. 11

    The Trauma Collaborative Care Study (TCCS) by Wegener, Stephen T, Pollak, Andrew N, Frey, Katherine P, Hymes, Robert A, Archer, Kristin R, Jones, Clifford B, Seymour, Rachel B, OʼToole, Robert V, Castillo, Renan C, Huang, Yanjie, Scharfstein, Daniel O, MacKenzie, Ellen J

    Published in Journal of orthopaedic trauma (01-04-2017)
    “…Previous research suggests that the care provided to trauma patients could be improved by including early screening and management of emotional distress and…”
    Get full text
    Journal Article
  12. 12